2-Chloro-1-nitro-3-(trifluoromethyl)benzene, 95.0%, 25g

(5-Bromo-2-methylthiazol-4-yl)methanol, 95%, 250mg

(1-(Tert-butyldimethylsilyl)-1H-indol-4-yl)boronic acid, 98+%, 1g

Methyl 4-bromo-3-hydroxy-5-methylthiophene-2-carboxylate, 98%, 1g

Nalpha-tert-Butoxycarbonyl-Nepsilon-tetradecanoyl-L-lysine>97.0%(T)200mg

Methyl 5-bromo-3-fluorothiophene-2-carboxylate, 98%, 1g

Reaction vials ROTILABO® 1.5 ml, 1.5 ml, 500 Piece(s)

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-homoserine, 97%, 250mg

2-bromo-1H-imidazo[4,5-b]pyridine, 97%, 5g

4-(trans-4-Amylcyclohexyl)benzoic Acid>98.0%(GC)(T)25g

2-Chloroimidazo[1,2-a]pyridine, 95.0%, 1g

5-Bromo-3-iodopyrazin-2-amine, 95.0%, 10g

(E)-4-Amino-N'-(3-chloro-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide, 98.0%, 500mg